APC148

AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections

AdjuTec Pharma has signed a €2.2 million Eurostars consortium agreement, spearheading an international effort to combat multidrug-resistant lung infections....

Intervju

AdjuTec Pharma's CEO: “Our goal is to set a new standard in antibiotic treatment”

Late last year, AdjuTec Pharma launched a phase...

Intervju

AdjuTec Pharma enters phase I with novel AMR treatment

AdjuTec Pharma has launched a phase I clinical...

Intervju

AdjuTec Pharma to start phase I trial with APC148

Adjutec is set to start its phase I...

Intervju

AdjuTec advances towards phase I with regulatory green light

Preparing to hit the clinical stage with its...

Intervju

Adjutec applies for phase I start

Norwegian AdjuTec Pharma prepares for clinical trials with...

Intervju

AdjuTec takes on global antimicrobial resistance

AdjuTec Pharma is determined in its mission to...

AdjuTec CEO aims for better and safer antibiotics

Norwegian pharmaceutical company AdjuTec Pharma is on a...

Intervju